The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands.
Journal:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published Date:
Jun 26, 2025
Abstract
OBJECTIVES: Population-wide screening for primary open-angle glaucoma (glaucoma) is typically not cost-effective because of low prevalence and high costs. We evaluated the cost-effectiveness of repeated artificial intelligence (AI)-based glaucoma screening using fundus photos in the Dutch population aged 50 to 75, compared with opportunistic case finding.